In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On April 20, NDASA...
Featured posts
All posts
Oral Fluid Testing: Soon, but not yet
Since the new 2020 U.S. Department of Transportation Custody and Control Form became available in September, one tiny addition has created a tremendous amount of confusion among employers, specimen collectors and others involved in DOT-mandated drug screening. The...
NDASA wins one for public safety
The National Drug & Alcohol Screening Association has had a major win today with language added to the MORE ACT that allows continued marijuana drug testing for DOT safety-sensitive workers! The MORE Act is an attempt to remove marijuana from the list of federally...
The new normal: How to ensure compliance during COVID-19
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
NDASA guidance and U.S. DOT response to COVID-19
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...